Repeated Endocardial Mapping for Efficacy Assessment After Catheter Ablation for Ischemic Ventricular Tachycardia
Launched by UNIVERSITY MEDICAL CENTRE LJUBLJANA · Jan 26, 2023
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Patients with ischemic ventricular tachycardia and implanted defibrillatior (ICD) will be sent to catheter ablation according to current guidelines (ESC and/or HRS). At the initial procedure the scar will be mapped with an ablation catheter and a high density catheter and all abnormal endocardial electrical potentials will be marked on a three-dimensional electro-anatomical (3DEAM) map; late potentials, local abnormal ventricular activity and decrement evoked electrical potentials. Afterwards, programed ventricular stimulation will be performed with an intent to induce sustained ventricular...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ischemic heart disease,
- • sustained ventricular tachycardia,
- • implanted (or scheduled for implantation) cardiac electrical device with ability to record and store intracardiac electrograms
- Exclusion Criteria:
- • nonischemic cardiomyopathy,
- • need for epicardial access to the substrate for treatment of ventricular tachycardia,
- • any severe acute organ damage beyond cardiomyopathy that could potentialy omit remapping procedure after 3 months,
- • any terminal disease with expected survival of less than one year
About University Medical Centre Ljubljana
University Medical Centre Ljubljana (UMCL) is a leading academic medical institution in Slovenia, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMCL integrates cutting-edge medical practices with comprehensive patient care, fostering an environment of collaboration among healthcare professionals, researchers, and patients. With a strong emphasis on ethical standards and scientific integrity, UMCL aims to contribute to the global body of medical knowledge while improving treatment outcomes in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ljubljana, , Slovenia
Patients applied
Trial Officials
Matevž Jan, MD
Study Chair
University Medical Centre Ljubljana
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials